← Open Payments lookup

RACHEL TINCHER: Open Payments

NPI 1457635468 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,316 in 67 payments from 17 companies in 2025. Trend: 2023 $1,455 · 2024 $642 · 2025 $1,316

Food & beverage: $1,316
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.9$266
E.R. Squibb & Sons, L.L.C.11$170
ABBVIE INC.10$155
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$144
Vanda Pharmaceuticals Inc.4$102
Neurocrine BioSciences, Inc.5$87
Lundbeck LLC4$82
Alkermes, Inc.4$76
Teva Pharmaceuticals USA, Inc.2$36
Axsome Therapeutics, Inc.2$34

Products named: ABILIFY MAINTENA, COBENFY, REXULTI, CAPLYTA, VRAYLAR, INGREZZA, ARISTADA, HETLIOZ.

Industry payments across NE — which companies pay providers there.